Prevention of influenza in the general population: recommendation statement from the Canadian Task Force on Preventive Health Care

Langley, Joanne M.; Faughnan, Marie E.
November 2004
CMAJ: Canadian Medical Association Journal;11/9/2004, Vol. 171 Issue 10, p1169
Academic Journal
Presents the recommendations from the Canadian Task Force on Preventive Health Care for the prevention of influenza. Implications of the disease for adults; Goal of influenza immunization programs; Disadvantages of influenza vaccines.


Related Articles

  • Flu test could cut vaccine workload.  // Pulse;9/6/2007, Vol. 67 Issue 31, p14 

    The article cites a study conducted by the West Scotland Specialist Virology Center that questioned the necessity of flu vaccination to individuals with pre-existing resistance. According to the study, previous vaccination provides all at-risk patients with pre-existing resistance capability to...

  • Influenza vaccines in adults. Jefferson, T.; Bianco, E.; Demicheli, V. // Occupational Medicine;Aug2002, Vol. 52 Issue 5, p255 

    Available influenza vaccines contain inactivated viruses, either whole or in parts, and are administered parenterally or intranasally. Their composition varies yearly because of viral antigenic shifts and drifts. Vaccines with a composition matching yearly World Health Organization...

  • General considerations.  // WHO Technical Report Series;2004, Issue 927, p102 

    The article provides information about influenza vaccines. Influenza vaccines usually contains one or more influenza A viruses. But it has been found out that vaccines containing prevalent viruses are expected to be less protective against virus variants which shows antigenic drift than against...

  • Flu shot success.  // New Scientist;9/24/2005, Vol. 187 Issue 2518, p4 

    This article discusses various ongoing efforts to develop flu vaccine. There is increasing evidence that the vaccination could save lives, especially if given to people over 65 and those likely to come into contact with them. Determining the benefits of flu shots has been difficult, partly...

  • Influenza warning as strains get nasty. Cameron, Amanda // New Zealand Doctor;2/11/2009, p3 

    The article reports on the release of a warning on the circulation of a more deadly strain of influenza virus together with rising antiviral resistance and low immunisation rates in New Zealand in 2009. It notes that the new influenza vaccine for 2009 contains a Brisbane H3N2-like strain, an...

  • Flu vaccinations now underway.  // Kai Tiaki Nursing New Zealand;Apr2015, Vol. 21 Issue 3, p9 

    No abstract available.

  • Using Live, Attenuated Influenza Vaccine for Prevention and Control of Influenza Supplemental Recommendations of the Advisory Committee on Immunization Practices (ACIP). Harper, Scott A.; Fukuda, Keiji; Cox, Nancy J.; Bridges, Carolyn B. // MMWR: Morbidity & Mortality Weekly Report;9/26/2003 Supplement, Vol. 52 Issue RR-13, p1 

    Summarizes recommendations by the Advisory Committee on Immunization Practices for using intranasally administered, trivalent, cold-adapted, live, attenuated influenza vaccine (LAIV), which was approved for use in the U.S. on June 17, 2003. Description and action mechanisms of LAIV; Comparison...

  • Safety of Trivalent Inactivated Influenza Vaccine in Children 6 to 23 Months Old. Hambidge, Simon J.; Glanz, Jason M.; France, Eric K.; McClure, David; Xu, Stanley; Yamasaki, Kristi; Jackson, Lisa; Mullooly, John P.; Zangwill, Kenneth M.; Marcy, S. Michael; Black, Steven B.; Lewis, Edwin M.; Shinefield, Henry R.; Belongia, Edward; Nordin, James; Chen, Robert T.; Shay, David K.; Davis, Robert L.; DeStefano, Frank // JAMA: Journal of the American Medical Association;10/25/2006, Vol. 296 Issue 16, p1990 

    The article presents a medical study examining the safety of trivalent inactivated influenza vaccine in children aged 6 to 23 months. The study participants were young children in the U.S. who received the trivalent inactivated influenza vaccine between January 1991 and May 2003. A chart review...

  • Reports of Expired Live Attenuated Influenza Vaccine Being Administered -- United States, 2007-2014. Haber, Penina; Schembri, Christopher P.; Lewis, Paige; Hibbs, Beth; Shimabukuro, Tom // MMWR: Morbidity & Mortality Weekly Report;9/5/2014, Vol. 63 Issue 35, p773 

    The article presents information on reports of expired live attenuated influenza vaccine (LAIV) administered between 2007-2014 in the U.S. There are two types of vaccine that are approved in the U.S. including injectable inactivated influenza vaccine (IIV) and LAIV. According to a report, from...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics